MarketWatch: Health Round-up

Summary

Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Healthcare industry.

Contents

• In This Month's Marketwatch
  • Pharmaceutical Company Round-Up
  • Cancer Update
  • News Round-Up
  • Opinion: Janssen-Cilag: Velcade Use Extended In Europe
  • Opinion: Merck & Co: Gardasil's Cost Efficacy Under Question
  • Opinion: Imclone/Bristol-Myers Squibb/Merck Serono: Erbitux
  • Disappoints In Lung Cancer
  • Cardiovascular Update
  • News Round-Up
  • Central Nervous System Update
  • News Round-Up
  • Opinion: Ucb: Vimpat Offers Hope To Sufferers Of Uncontrolled
  • Epilepsy
  • Opinion: Allergan: New Data Suggest Botox Treats Chronic Migraine
  • Opinion: Pfizer And Medivation: Dimebon Co-Development
  • Agreement
  • Idi Update
  • News Round-Up
  • Opinion: Anti-Tnfs: Fda Calls For Additional Warnings On Blockbuster
  • Class
  • Infectious Diseases Update
  • News Round-Up
  • Opinion: Pfizer: Withdraws Zeven Marketing Applications
  • Industry Update
  • Feature Analysis: Is Cost Containment Impacting Pharmaceutical
  • Innovation?
  • Feature Analysis: Is An Rx-To-Otc Move The Right Prescription To
  • Protect Pharma Revenues And Cut Healthcare
  • Costs?
  • Company Spotlight
  • Bristol-Myers Squibb
  • Biotechnology Update
  • News Round-Up
  • Feature Analysis: Monoclonal Antibody Sales To Almost Double By
  • 2013
  • Opinion: Eli Lilly: Completes Sgx Acquisition
  • Biotechnology Company Spotlight
  • Sigma-Aldrich Corporation
  • Further Reading
  • Index
  • Pharma Companies
  • Biotech Companies
  • Key Drugs